Ani Pharmaceuticals reported $96.31M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Aerie Pharmaceuticals AERI:US $ 119.66M 4.37M
Ani Pharmaceuticals ANIP:US $ 96.31M 16.78M
Aurora Cannabis Inc ACB:CN 119.06M 3.8M
Canopy Growth Corp WEED:CN C$ 404.41M 191.51M
Depomed DEPO:US $ 116.15M 22.38M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Emergent Biosolutions EBS:US $ 276.7M 27.5M
Endo International Ordinary Shares ENDP:US $ 1181.67M 194.47M
Heron Therapeutics HRTX:US $ 109.5M 16.5M
Hikma Pharmaceutical HIK:LN 1.01B 6M
Knight Therapeutics Inc GUD:CN C$ 126.03M 4.72M
Lannett LCI:US $ 94.36M 5.1M
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Novartis NVS:US $ 27646M 2161M
Omeros OMER:US $ 38.5M 3.44M
Perrigo Ordinary Shares PRGO:US $ 1014.6M 33.3M
Teva Pharmaceutical TEVA:IT 11B 617M
Teva Pharmaceutical Industries TEVA:US $ 10996M 617M